Totus Medicines
27 employees on LinkedIn · 3 known investors
Find your way into Totus Medicines
Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
Founders & leadership
ND
Neil Dhawan, PhDCo-Founder
NU
Nassim Usman, PhDCEO and President
Investors · 3
DCVC (Data Collective)listed by DCVC (Data Collective)Palo Alto · $5M – $25M
How we know: a partner's Signal profile · the VCSheet dataset · Not right? Tell us
DCVC BioreportedPalo Alto
How we know: a partner's Signal profile · funding news · Not right? Tell us
Social Impact CapitalreportedNew York · $100K – $1.5M
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BDec 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Totus Medicines do?
- Totus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
- Who founded Totus Medicines?
- Totus Medicines was founded by Neil Dhawan, PhD.
- Who are Totus Medicines's investors?
- Totus Medicines's investors include DCVC (Data Collective), DCVC Bio, Social Impact Capital.

